Ducommun Incorporated (DCO)

Augmedix Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	789.82	786.55	756.99	712.54	645.41	628.94
Revenue Growth (YoY)	3.02%	3.91%	6.24%	10.40%	2.62%	-12.78%
Cost of Revenue	586.69	588.07	593.49	567.71	503.85	491.2
Gross Profit	203.13	198.48	163.5	144.83	141.56	137.74
Selling, General & Admin	137.11	135.47	118.43	98.35	93.68	89.81
Operating Expenses	137.11	135.47	118.43	98.35	93.68	89.81
Operating Income	66.02	63.01	45.07	46.47	47.88	47.93
Interest Expense	-14.68	-15.3	-20.77	-11.57	-11.19	-13.65
Other Non Operating Income (Expenses)	-	-	4.44	-	0.27	0.13
EBT Excluding Unusual Items	51.34	47.71	28.73	34.9	36.96	34.41
Merger & Restructuring Charges	-9.86	-10.8	-16.16	-6.69	-	-2.42
Gain (Loss) on Sale of Assets	-	-	-	-	132.52	-
Other Unusual Items	-	-	-	-0.3	1	-
Pretax Income	41.48	36.91	16.38	33.32	170.48	31.98
Income Tax Expense	6.33	5.41	0.45	4.53	34.95	2.81
Net Income	35.16	31.5	15.93	28.79	135.54	29.17
Net Income to Common	35.16	31.5	15.93	28.79	135.54	29.17
Net Income Growth	100.37%	97.73%	-44.67%	-78.76%	364.58%	-10.13%
Shares Outstanding (Basic)	15	15	14	12	12	12
Shares Outstanding (Diluted)	15	15	14	12	12	12
Shares Change (YoY)	3.44%	7.45%	12.99%	0.94%	2.67%	1.19%
EPS (Basic)	2.37	2.13	1.16	2.38	11.41	2.50
EPS (Diluted)	2.33	2.10	1.14	2.33	11.06	2.45
EPS Growth	93.69%	84.21%	-51.07%	-78.93%	351.43%	-10.91%
Free Cash Flow	22.63	20.05	11.55	12.99	-17.43	0.1
Free Cash Flow Per Share	1.50	1.34	0.83	1.05	-1.42	0.01
Gross Margin	25.72%	25.23%	21.60%	20.32%	21.93%	21.90%
Operating Margin	8.36%	8.01%	5.95%	6.52%	7.42%	7.62%
Profit Margin	4.45%	4.00%	2.10%	4.04%	21.00%	4.64%
Free Cash Flow Margin	2.86%	2.55%	1.52%	1.82%	-2.70%	0.02%
EBITDA	99.69	96.45	77.64	77.9	76.27	76.78
EBITDA Margin	12.62%	12.26%	10.26%	10.93%	11.82%	12.21%
D&A For EBITDA	33.67	33.44	32.57	31.42	28.39	28.85
EBIT	66.02	63.01	45.07	46.47	47.88	47.93
EBIT Margin	8.36%	8.01%	5.95%	6.52%	7.42%	7.62%
Effective Tax Rate	15.25%	14.66%	2.75%	13.60%	20.50%	8.78%

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q